Labshares Newton, an office and laboratory incubator for emerging biotechnology and life science companies, announced the launch of its first location in Newton.

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, has entered into a strategic agreement valued at up to $202 million with an undisclosed, large commercial-stage biopharmaceutical company ...